Archives

by in
Entry Author Date Location
Ra Pharma Pours $8.6M Into Discovery Tech and New Rare-Disease Drug 05/23/12 Boston
Ra Pharmaceuticals Receives $8,600,000 Series A Financing Round 05/16/12 Boston
Sutro Biopharma Pulls in $16M for New Antibody Drugs 05/08/12 San Francisco
Allozyne, Poniard Scrap Plan to Merge Amid Investor Apathy 12/22/11 Seattle
Theraclone Snaps Up $10.6M Financing 09/08/11 Seattle
Theraclone Sciences Secures $10,600,000 Series B Round 09/08/11 Seattle
Ardelyx Nabs $30M To Develop Drug for Irritable Bowel Syndrome, and High Blood Pressure 08/31/11 San Francisco
Ardelyx Garners $30,000,000 Series B Funding 08/31/11 San Francisco
Oncofactor Garners $2,100,000 Series A Financing Round 05/25/11 Seattle
Gilead Buys Calistoga Pharma for $375M, Making Move Into Cancer Drugs 02/22/11 Seattle
Theraclone Strikes $632M Deal With Pfizer to Discover Antibodies for Cancer, Infections 01/18/11 Seattle
Allozyne Passes First Clinical Trial, Dreams Big About a Once-Monthly Multiple Sclerosis Drug 01/10/11 Seattle
Accelerator Reaches Out to East Coast to Find Latest Startup, Acylin Therapeutics 12/01/10 Seattle
Sutro Biopharma Grabs $36.5M in Venture Deal to Make “Biobetters” 11/17/10 San Francisco
Sutro Biopharma Secures $36,500,000 Series C Round 11/17/10 San Francisco
Biotech DecImmune Grabs $1M from Astellas VC 09/27/10 Boston
DecImmune Therapeutics Lands $1,000,000 New Funding Round 09/27/10 Boston
Allozyne, After a Stealthy Year on a Slim Budget, Re-Emerges with MS Drug and Fat Pipeline 07/14/10 Seattle
Calistoga Pharmaceuticals Nabs $40M in Washington’s Biggest Venture Deal of 2010 06/30/10 Seattle
Calistoga Pharmaceuticals Garners $40,000,000 Series C Funding 06/30/10 Seattle
Theraclone Sciences CEO David Fanning Dies Suddenly 06/14/10 Seattle
Avvo Follows Amazon and Expedia, Ignition and General Catalyst Back Travel Startup, Gist Goes Networking, & More Seattle-Area Deals News 03/23/10 Seattle
Theraclone Raises $1.5M 03/19/10 Seattle
VLST Cuts Jobs To Preserve Cash, Still Feeding Novo Nordisk Pipeline 12/22/09 Seattle
Epizyme Tacks On Extra $8M Financing For Drugs that Turn Genes On or Off 12/08/09 Boston
Santaris Nabs Isis, Amgen Vets 10/28/09 San Diego
Top 10 (+ 1) New England Venture Deals of Q3 2009 10/20/09 Boston
Calistoga Cancer Drug Shows “Encouraging” Preliminary Results in Small Study 10/19/09 Seattle
Epizyme Grabs $32M, A123 Systems’ IPO Enriches BU, & More Boston-Area Deals News 10/12/09 Boston
Public Biotechs’ Finances Foundering, Epizyme Banks $32M, Paratek Cuts Deal with Novartis, & More Boston-Area Life Sciences News 10/09/09 Boston
Page 1 of 2 next page »
    

Xconomy Events Across the Network

The Napa Summit: Keeping America Growing

San Francisco · 6/7/12

More Xconomy Events

Xconomy’s Most Popular

  1. ASCO Preview: Eight Cancer Drugs to Watch at the Big Show
  2. Biotech IPOs Start to Show Some Modest Signs of Life
  3. Hey, Silicon Valley: Wake Up and Smell the Robots
  4. From MIT Entrepreneur to Tea Party Leader: The Thomas Massie Story
  5. Announcing Xconomy’s Napa Summit: Keeping America Growing

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.